Rastogi Archana, Sakhuja Puja, Kumar Ashish, Hissar Syed, Jain Akshat, Gondal Ranjana, Sarin Shiv Kumar
Department of Pathology, GB Pant Hospital, New Delhi, India.
Indian J Pathol Microbiol. 2011 Jul-Sep;54(3):454-9. doi: 10.4103/0377-4929.85074.
Hepatic steatosis (HS) is highly prevalent in chronic hepatitis C and is an important variable predicting progression of histological injury, insulin resistance, and reduced response to antiviral therapy. There are limited data on HS in patients with chronic hepatitis B (CHB). This is relevant since response to current antiviral therapies for CHB is rather limited. We investigated the spectrum and predictors of HS in CHB patients.
Liver biopsies of consecutive patients of chronic Hepatitis B Virus (HBV) infection were studied and were categorized as: Group I - hepatosteatosis (>5%) and Group II - no steatosis (£5%). Anthropometric, histological, biochemical, virological, and metabolic determinants were compared. Logistic regression analysis was applied to identify variables that were independently associated with the presence of steatosis.
Of the 350 patients, 118 (33.7%) liver biopsies showed steatosis (Group I); 65 (55.1%) had mild (6 to <25%) and 53 (44.9%) had moderate to severe steatosis ((3)25%). Patients in group I, compared with group II, were older (35.5 ± 10.5 vs 27.9 ± 14.0 years, P < 0.01), predominantly male (M: F, 10.8: 1 vs 4.8: 1, P = 0.035), obese (75.0% vs 23.4%, P P < 0.01), with higher triglycerides (138.8 ± 62.1 vs 88.0 ± 27.9, P = 0.02), with higher cholesterol (171.9 ± 43.5 vs 139.3 ± 37.6, P = 0.017), and with higher serum insulin (13.1 ± 9.1 vs 9.1 ± 6.0, P < .027) levels. HBV DNA level was significantly lower in group I than group II; however, HBV genotype did not influence HS. By multivariate regression analysis, only high serum triglyceride level was independent parameter associated with HS.
Steatosis is seen in one-third cases with HBV-related chronic liver disease and is associated with host metabolic factors, especially serum triglyceride levels, whereas HBV DNA level negatively correlated with HS.
肝脂肪变性(HS)在慢性丙型肝炎中极为常见,是预测组织学损伤进展、胰岛素抵抗及抗病毒治疗反应降低的重要变量。关于慢性乙型肝炎(CHB)患者肝脂肪变性的数据有限。鉴于目前针对CHB的抗病毒治疗反应相当有限,这一情况具有重要意义。我们调查了CHB患者肝脂肪变性的范围及预测因素。
对连续的慢性乙型肝炎病毒(HBV)感染患者的肝活检组织进行研究,并分为:I组 - 肝脂肪变性(>5%)和II组 - 无脂肪变性(≤5%)。比较人体测量学、组织学、生化、病毒学及代谢指标。应用逻辑回归分析确定与脂肪变性存在独立相关的变量。
350例患者中,118例(33.7%)肝活检显示有脂肪变性(I组);65例(55.1%)为轻度(6%至<25%),53例(44.9%)为中度至重度脂肪变性(≥25%)。与II组相比,I组患者年龄更大(35.5±10.5岁对27.9±14.0岁,P<0.01),男性居多(男:女,10.8:1对4.8:1,P = 0.035),肥胖者更多(75.0%对23.4%,P<0.01),甘油三酯水平更高(138.8±62.1对88.0±27.9,P = 0.02),胆固醇水平更高(171.9±43.5对139.3±37.6,P = 0.017),血清胰岛素水平更高(13.1±9.1对9.1±6.0,P<0.027)。I组HBV DNA水平显著低于II组;然而,HBV基因型不影响肝脂肪变性。多因素回归分析显示,只有高血清甘油三酯水平是与肝脂肪变性相关的独立参数。
在三分之一的HBV相关慢性肝病病例中可见脂肪变性,且与宿主代谢因素相关,尤其是血清甘油三酯水平,而HBV DNA水平与肝脂肪变性呈负相关。